
Deborah Crouch
Examiner (ID: 19500, Phone: (571)272-0727 , Office: P/1632 )
| Most Active Art Unit | 1632 |
| Art Unit(s) | 3725, 1819, 1632, 2899, 1804 |
| Total Applications | 1439 |
| Issued Applications | 694 |
| Pending Applications | 237 |
| Abandoned Applications | 511 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5379320
[patent_doc_number] => 20090191159
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-30
[patent_title] => 'Multipotent/pluripotent cells and methods'
[patent_app_type] => utility
[patent_app_number] => 12/157967
[patent_app_country] => US
[patent_app_date] => 2008-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 115786
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20090191159.pdf
[firstpage_image] =>[orig_patent_app_number] => 12157967
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/157967 | Induced pluripotent stem cells produced using reprogramming factors and a rho kinase inhibitor or a histone deacetylase inhibitor | Jun 12, 2008 | Issued |
Array
(
[id] => 5446037
[patent_doc_number] => 20090047263
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-19
[patent_title] => 'Nuclear reprogramming factor and induced pluripotent stem cells'
[patent_app_type] => utility
[patent_app_number] => 12/213035
[patent_app_country] => US
[patent_app_date] => 2008-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 57
[patent_figures_cnt] => 57
[patent_no_of_words] => 29287
[patent_no_of_claims] => 89
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0047/20090047263.pdf
[firstpage_image] =>[orig_patent_app_number] => 12213035
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/213035 | Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2 | Jun 12, 2008 | Issued |
Array
(
[id] => 5336718
[patent_doc_number] => 20090053182
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-26
[patent_title] => 'ENDOMETRIAL STEM CELLS AND METHODS OF MAKING AND USING SAME'
[patent_app_type] => utility
[patent_app_number] => 12/127697
[patent_app_country] => US
[patent_app_date] => 2008-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 30011
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20090053182.pdf
[firstpage_image] =>[orig_patent_app_number] => 12127697
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/127697 | ENDOMETRIAL STEM CELLS AND METHODS OF MAKING AND USING SAME | May 26, 2008 | Abandoned |
Array
(
[id] => 7518748
[patent_doc_number] => 07972849
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-07-05
[patent_title] => 'Primate pluripotent stem cells produced by somatic cell nuclear transfer'
[patent_app_type] => utility
[patent_app_number] => 12/122557
[patent_app_country] => US
[patent_app_date] => 2008-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 32255
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/972/07972849.pdf
[firstpage_image] =>[orig_patent_app_number] => 12122557
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/122557 | Primate pluripotent stem cells produced by somatic cell nuclear transfer | May 15, 2008 | Issued |
Array
(
[id] => 6293020
[patent_doc_number] => 20100239671
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-23
[patent_title] => 'Tissue-Engineered Endothelial and Epithelial Implants Differentially and Synergistically Regulate Tissue Repair'
[patent_app_type] => utility
[patent_app_number] => 12/738956
[patent_app_country] => US
[patent_app_date] => 2008-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13161
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20100239671.pdf
[firstpage_image] =>[orig_patent_app_number] => 12738956
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/738956 | Tissue-Engineered Endothelial and Epithelial Implants Differentially and Synergistically Regulate Tissue Repair | May 5, 2008 | Abandoned |
Array
(
[id] => 9869096
[patent_doc_number] => 08956866
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-02-17
[patent_title] => 'Retinal pigment epithelial cells differentiated from embryonic stem cells with nicotinamide and activin A'
[patent_app_type] => utility
[patent_app_number] => 12/450943
[patent_app_country] => US
[patent_app_date] => 2008-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 144
[patent_no_of_words] => 18291
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12450943
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/450943 | Retinal pigment epithelial cells differentiated from embryonic stem cells with nicotinamide and activin A | Apr 26, 2008 | Issued |
Array
(
[id] => 5558268
[patent_doc_number] => 20090269845
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-29
[patent_title] => 'PLURIPOTENT CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/108872
[patent_app_country] => US
[patent_app_date] => 2008-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 50
[patent_no_of_words] => 22029
[patent_no_of_claims] => 83
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20090269845.pdf
[firstpage_image] =>[orig_patent_app_number] => 12108872
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/108872 | Cells expressing pluripotency markers and expressing markers characteristic of the definitive endoderm | Apr 23, 2008 | Issued |
Array
(
[id] => 5355063
[patent_doc_number] => 20090186407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-23
[patent_title] => 'Alternative Compositions and Methods for the Culture of Stem Cells'
[patent_app_type] => utility
[patent_app_number] => 12/104364
[patent_app_country] => US
[patent_app_date] => 2008-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 23241
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20090186407.pdf
[firstpage_image] =>[orig_patent_app_number] => 12104364
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/104364 | Alternative Compositions and Methods for the Culture of Stem Cells | Apr 15, 2008 | Abandoned |
Array
(
[id] => 5580486
[patent_doc_number] => 20090175832
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-09
[patent_title] => 'Isolated Embryonic-Like Stem Cells Derived From Human Umbilical Cord Blood'
[patent_app_type] => utility
[patent_app_number] => 12/099054
[patent_app_country] => US
[patent_app_date] => 2008-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 26454
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20090175832.pdf
[firstpage_image] =>[orig_patent_app_number] => 12099054
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/099054 | Isolation of CD14 negative, CD45 positive and CD117 positive embryonic-like stem cells free of monocytes from human umbilical cord blood mononuclear cells | Apr 6, 2008 | Issued |
Array
(
[id] => 4948960
[patent_doc_number] => 20080305086
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-11
[patent_title] => 'HUMAN LATE STAGE MOTOR NEURON PROGENITOR CELLS AND METHODS OF MAKING AND USING SAME'
[patent_app_type] => utility
[patent_app_number] => 12/054245
[patent_app_country] => US
[patent_app_date] => 2008-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 14768
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0305/20080305086.pdf
[firstpage_image] =>[orig_patent_app_number] => 12054245
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/054245 | Preparing a population of human late stage motor neuron progenitor cells | Mar 23, 2008 | Issued |
Array
(
[id] => 8802187
[patent_doc_number] => 08440461
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-05-14
[patent_title] => 'Reprogramming somatic cells using retroviral vectors comprising Oct-4 and Sox2 genes'
[patent_app_type] => utility
[patent_app_number] => 12/053440
[patent_app_country] => US
[patent_app_date] => 2008-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 12313
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12053440
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/053440 | Reprogramming somatic cells using retroviral vectors comprising Oct-4 and Sox2 genes | Mar 20, 2008 | Issued |
Array
(
[id] => 6289409
[patent_doc_number] => 20100158805
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-24
[patent_title] => 'QUANTUM DOT LABELED STEM CELLS FOR USE IN CARDIAC REPAIR'
[patent_app_type] => utility
[patent_app_number] => 12/532780
[patent_app_country] => US
[patent_app_date] => 2008-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 17643
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20100158805.pdf
[firstpage_image] =>[orig_patent_app_number] => 12532780
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/532780 | QUANTUM DOT LABELED STEM CELLS FOR USE IN CARDIAC REPAIR | Mar 20, 2008 | Abandoned |
Array
(
[id] => 5296577
[patent_doc_number] => 20090011503
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-08
[patent_title] => 'Primate Embryonic Stem Cells'
[patent_app_type] => utility
[patent_app_number] => 12/047135
[patent_app_country] => US
[patent_app_date] => 2008-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10028
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0011/20090011503.pdf
[firstpage_image] =>[orig_patent_app_number] => 12047135
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/047135 | Spontaneous differentiation of human embryonic stem cells in culture | Mar 11, 2008 | Issued |
Array
(
[id] => 9140559
[patent_doc_number] => 08581021
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-11-12
[patent_title] => 'Pig whose genome comprises a heterologous site-specific recombination site and a transpohon tag'
[patent_app_type] => utility
[patent_app_number] => 12/529958
[patent_app_country] => US
[patent_app_date] => 2008-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 37336
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12529958
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/529958 | Pig whose genome comprises a heterologous site-specific recombination site and a transpohon tag | Mar 6, 2008 | Issued |
Array
(
[id] => 4697772
[patent_doc_number] => 20080219956
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-11
[patent_title] => 'HLA HOMOZYGOUS CELLS AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/044471
[patent_app_country] => US
[patent_app_date] => 2008-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 47
[patent_no_of_words] => 13826
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20080219956.pdf
[firstpage_image] =>[orig_patent_app_number] => 12044471
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/044471 | Parvoviral production of HLA homozygous cells | Mar 6, 2008 | Issued |
Array
(
[id] => 6254328
[patent_doc_number] => 20100138940
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-03
[patent_title] => 'TRANSGENIC PIG AS A MODEL OF ALZHEIMER\'S DISEASE'
[patent_app_type] => utility
[patent_app_number] => 12/529963
[patent_app_country] => US
[patent_app_date] => 2008-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 54615
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0138/20100138940.pdf
[firstpage_image] =>[orig_patent_app_number] => 12529963
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/529963 | Transgenic pig as a model of Alzheimer's disease | Mar 5, 2008 | Issued |
Array
(
[id] => 5539191
[patent_doc_number] => 20090220996
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-03
[patent_title] => 'In vitro Assay Methods for Classifying Embryotoxicity of Compounds'
[patent_app_type] => utility
[patent_app_number] => 12/043899
[patent_app_country] => US
[patent_app_date] => 2008-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 13128
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20090220996.pdf
[firstpage_image] =>[orig_patent_app_number] => 12043899
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/043899 | In vitro Assay Methods for Classifying Embryotoxicity of Compounds | Mar 5, 2008 | Abandoned |
Array
(
[id] => 6294971
[patent_doc_number] => 20100240132
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-23
[patent_title] => 'HIGHLY EFFICIENT METHODS FOR REPROGRAMMING DIFFERENTIATED CELLS AND FOR GENERATING ANIMALS AND EMBRYONIC STEM CELLS FROM REPROGRAMMED CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/528212
[patent_app_country] => US
[patent_app_date] => 2008-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 32601
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0240/20100240132.pdf
[firstpage_image] =>[orig_patent_app_number] => 12528212
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/528212 | Blastomere culture to produce mammalian embryonic stem cells | Feb 21, 2008 | Issued |
Array
(
[id] => 5360488
[patent_doc_number] => 20090035282
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-05
[patent_title] => 'Pluripotent embryonic-like stem cells derived from teeth and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/068695
[patent_app_country] => US
[patent_app_date] => 2008-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 13777
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20090035282.pdf
[firstpage_image] =>[orig_patent_app_number] => 12068695
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/068695 | Human dental follicle stem cells and methods for obtaining | Feb 10, 2008 | Issued |
Array
(
[id] => 6601819
[patent_doc_number] => 20100098736
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-22
[patent_title] => 'CONNECTIVE TISSUE REPAIR'
[patent_app_type] => utility
[patent_app_number] => 12/526194
[patent_app_country] => US
[patent_app_date] => 2008-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 4009
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20100098736.pdf
[firstpage_image] =>[orig_patent_app_number] => 12526194
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/526194 | Isolation of human articular cartilage stem cells | Feb 5, 2008 | Issued |